Fluconazole - a case report on fixed drug eruption

Detalhes bibliográficos
Autor(a) principal: Correia, Magna
Data de Publicação: 2014
Outros Autores: Freitas, João, Vieira, Rita, Perneta, Filipe, Brazão, Luz
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.26/32999
Resumo: Adverse reactions to drugs, Fixed Erythema (FE), correspond to 16-21% of all skin eruptions. This disease results in the development of one or more erythematous annular or oval, plaques as a result of systemic exposure to a drug. On reexposure relapse occurs in the same place, although new lesions may arise simultaneously in other areas. Any drug can cause FE. The physiopathology involves an allergic reaction (vasculitis).
id RCAP_9a64a8f734832f4b0586aebba4cc5693
oai_identifier_str oai:comum.rcaap.pt:10400.26/32999
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Fluconazole - a case report on fixed drug eruptionflucanazoleanamnesisreaçºoes adversasvasculitisAdverse reactions to drugs, Fixed Erythema (FE), correspond to 16-21% of all skin eruptions. This disease results in the development of one or more erythematous annular or oval, plaques as a result of systemic exposure to a drug. On reexposure relapse occurs in the same place, although new lesions may arise simultaneously in other areas. Any drug can cause FE. The physiopathology involves an allergic reaction (vasculitis).Nature ResearchRepositório ComumCorreia, MagnaFreitas, JoãoVieira, RitaPerneta, FilipeBrazão, Luz2020-07-27T14:28:09Z20142014-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.26/32999porCorreia et al. Clinical and Translational Allergy 2014, 4(Suppl 3):P7210.1186/2045-7022-4-S3-P72info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-10T02:16:47Zoai:comum.rcaap.pt:10400.26/32999Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T22:34:27.070174Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Fluconazole - a case report on fixed drug eruption
title Fluconazole - a case report on fixed drug eruption
spellingShingle Fluconazole - a case report on fixed drug eruption
Correia, Magna
flucanazole
anamnesis
reaçºoes adversas
vasculitis
title_short Fluconazole - a case report on fixed drug eruption
title_full Fluconazole - a case report on fixed drug eruption
title_fullStr Fluconazole - a case report on fixed drug eruption
title_full_unstemmed Fluconazole - a case report on fixed drug eruption
title_sort Fluconazole - a case report on fixed drug eruption
author Correia, Magna
author_facet Correia, Magna
Freitas, João
Vieira, Rita
Perneta, Filipe
Brazão, Luz
author_role author
author2 Freitas, João
Vieira, Rita
Perneta, Filipe
Brazão, Luz
author2_role author
author
author
author
dc.contributor.none.fl_str_mv Repositório Comum
dc.contributor.author.fl_str_mv Correia, Magna
Freitas, João
Vieira, Rita
Perneta, Filipe
Brazão, Luz
dc.subject.por.fl_str_mv flucanazole
anamnesis
reaçºoes adversas
vasculitis
topic flucanazole
anamnesis
reaçºoes adversas
vasculitis
description Adverse reactions to drugs, Fixed Erythema (FE), correspond to 16-21% of all skin eruptions. This disease results in the development of one or more erythematous annular or oval, plaques as a result of systemic exposure to a drug. On reexposure relapse occurs in the same place, although new lesions may arise simultaneously in other areas. Any drug can cause FE. The physiopathology involves an allergic reaction (vasculitis).
publishDate 2014
dc.date.none.fl_str_mv 2014
2014-01-01T00:00:00Z
2020-07-27T14:28:09Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.26/32999
url http://hdl.handle.net/10400.26/32999
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Correia et al. Clinical and Translational Allergy 2014, 4(Suppl 3):P72
10.1186/2045-7022-4-S3-P72
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Nature Research
publisher.none.fl_str_mv Nature Research
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134906498940928

Registros relacionados